Risk of cancer among relatives of patients with glioma

Brian Patrick O'Neill, Hannes Blondal, Ping Yang, Gurri H. Olafsdottir, H. Sigvaldason, Robert Brian Jenkins, David W. Kimmel, Bernd W. Scheithauer, Walter A Rocca, Johannes Bjornsson, Hfran Tulinius

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

We report a population-based, retrospective study of 396 Icelandic people diagnosed with glioma in the years 1940-1995. The purpose of this study was to test whether astrocytomas, other glial tumors, other central nervous system tumors, or other cancers aggregate in families identified through glioma probands who were of Icelandic origin. Pedigrees of the 396 cases were traced by the Genetical Committee of the University of Iceland and linked to the Icelandic Cancer Registry. A total of 25,546 relatives, including 2,080 individuals with cancer were identified within these pedigrees. There was no statistically significant increase of glioma in relatives of glioma patients, nor was there any statistically significant increase in risk for other central nervous system tumors. There was no overall increase in incidence of all cancer combined, nor of specific common cancers (lung, prostate, breast, stomach, and colorectal) and uncommon cancers (melanoma and pancreas) in the relatives of glioma patients. Our results do not support the hypothesis of a familial aggregation of glioma indicative of a glioma susceptibility gene.

Original languageEnglish (US)
Pages (from-to)921-924
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume11
Issue number9
StatePublished - Sep 2002

Fingerprint

Glioma
Neoplasms
Central Nervous System Neoplasms
Pedigree
Iceland
Astrocytoma
Pancreatic Neoplasms
Neuroglia
Registries
Colorectal Neoplasms
Melanoma
Lung Neoplasms
Prostatic Neoplasms
Stomach
Breast
Retrospective Studies
Incidence
Population
Genes

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

O'Neill, B. P., Blondal, H., Yang, P., Olafsdottir, G. H., Sigvaldason, H., Jenkins, R. B., ... Tulinius, H. (2002). Risk of cancer among relatives of patients with glioma. Cancer Epidemiology Biomarkers and Prevention, 11(9), 921-924.

Risk of cancer among relatives of patients with glioma. / O'Neill, Brian Patrick; Blondal, Hannes; Yang, Ping; Olafsdottir, Gurri H.; Sigvaldason, H.; Jenkins, Robert Brian; Kimmel, David W.; Scheithauer, Bernd W.; Rocca, Walter A; Bjornsson, Johannes; Tulinius, Hfran.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 11, No. 9, 09.2002, p. 921-924.

Research output: Contribution to journalArticle

O'Neill, BP, Blondal, H, Yang, P, Olafsdottir, GH, Sigvaldason, H, Jenkins, RB, Kimmel, DW, Scheithauer, BW, Rocca, WA, Bjornsson, J & Tulinius, H 2002, 'Risk of cancer among relatives of patients with glioma', Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 9, pp. 921-924.
O'Neill, Brian Patrick ; Blondal, Hannes ; Yang, Ping ; Olafsdottir, Gurri H. ; Sigvaldason, H. ; Jenkins, Robert Brian ; Kimmel, David W. ; Scheithauer, Bernd W. ; Rocca, Walter A ; Bjornsson, Johannes ; Tulinius, Hfran. / Risk of cancer among relatives of patients with glioma. In: Cancer Epidemiology Biomarkers and Prevention. 2002 ; Vol. 11, No. 9. pp. 921-924.
@article{35f80ed1bb5e4cdca8c0f46a3117763a,
title = "Risk of cancer among relatives of patients with glioma",
abstract = "We report a population-based, retrospective study of 396 Icelandic people diagnosed with glioma in the years 1940-1995. The purpose of this study was to test whether astrocytomas, other glial tumors, other central nervous system tumors, or other cancers aggregate in families identified through glioma probands who were of Icelandic origin. Pedigrees of the 396 cases were traced by the Genetical Committee of the University of Iceland and linked to the Icelandic Cancer Registry. A total of 25,546 relatives, including 2,080 individuals with cancer were identified within these pedigrees. There was no statistically significant increase of glioma in relatives of glioma patients, nor was there any statistically significant increase in risk for other central nervous system tumors. There was no overall increase in incidence of all cancer combined, nor of specific common cancers (lung, prostate, breast, stomach, and colorectal) and uncommon cancers (melanoma and pancreas) in the relatives of glioma patients. Our results do not support the hypothesis of a familial aggregation of glioma indicative of a glioma susceptibility gene.",
author = "O'Neill, {Brian Patrick} and Hannes Blondal and Ping Yang and Olafsdottir, {Gurri H.} and H. Sigvaldason and Jenkins, {Robert Brian} and Kimmel, {David W.} and Scheithauer, {Bernd W.} and Rocca, {Walter A} and Johannes Bjornsson and Hfran Tulinius",
year = "2002",
month = "9",
language = "English (US)",
volume = "11",
pages = "921--924",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Risk of cancer among relatives of patients with glioma

AU - O'Neill, Brian Patrick

AU - Blondal, Hannes

AU - Yang, Ping

AU - Olafsdottir, Gurri H.

AU - Sigvaldason, H.

AU - Jenkins, Robert Brian

AU - Kimmel, David W.

AU - Scheithauer, Bernd W.

AU - Rocca, Walter A

AU - Bjornsson, Johannes

AU - Tulinius, Hfran

PY - 2002/9

Y1 - 2002/9

N2 - We report a population-based, retrospective study of 396 Icelandic people diagnosed with glioma in the years 1940-1995. The purpose of this study was to test whether astrocytomas, other glial tumors, other central nervous system tumors, or other cancers aggregate in families identified through glioma probands who were of Icelandic origin. Pedigrees of the 396 cases were traced by the Genetical Committee of the University of Iceland and linked to the Icelandic Cancer Registry. A total of 25,546 relatives, including 2,080 individuals with cancer were identified within these pedigrees. There was no statistically significant increase of glioma in relatives of glioma patients, nor was there any statistically significant increase in risk for other central nervous system tumors. There was no overall increase in incidence of all cancer combined, nor of specific common cancers (lung, prostate, breast, stomach, and colorectal) and uncommon cancers (melanoma and pancreas) in the relatives of glioma patients. Our results do not support the hypothesis of a familial aggregation of glioma indicative of a glioma susceptibility gene.

AB - We report a population-based, retrospective study of 396 Icelandic people diagnosed with glioma in the years 1940-1995. The purpose of this study was to test whether astrocytomas, other glial tumors, other central nervous system tumors, or other cancers aggregate in families identified through glioma probands who were of Icelandic origin. Pedigrees of the 396 cases were traced by the Genetical Committee of the University of Iceland and linked to the Icelandic Cancer Registry. A total of 25,546 relatives, including 2,080 individuals with cancer were identified within these pedigrees. There was no statistically significant increase of glioma in relatives of glioma patients, nor was there any statistically significant increase in risk for other central nervous system tumors. There was no overall increase in incidence of all cancer combined, nor of specific common cancers (lung, prostate, breast, stomach, and colorectal) and uncommon cancers (melanoma and pancreas) in the relatives of glioma patients. Our results do not support the hypothesis of a familial aggregation of glioma indicative of a glioma susceptibility gene.

UR - http://www.scopus.com/inward/record.url?scp=0036715339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036715339&partnerID=8YFLogxK

M3 - Article

C2 - 12223439

AN - SCOPUS:0036715339

VL - 11

SP - 921

EP - 924

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 9

ER -